40 likes | 52 Views
Rising number of drug-treated patients for ADHD therapy is expected to drive the attention deficit hyperactivity disorder (ADHD) treatment market
E N D
Attention-deficit/Hyperactivity Disorder (ADHD) Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Treatment Market Size, Share, Trend, Outlook, Market Size, Share, Trend, Outlook, Future Analysis And Synthesis By 2026 Future Analysis And Synthesis By 2026 Attention deficit hyperactivity disorder (ADHD) is a neural disorder. The disorder is characterized by impulsiveness, hyperactivity, and attention difficulty. Treatment of ADHD involves a combination of counseling, medications, and lifestyle changes. ADHD is the most commonly diagnosed mental disorder in adults and children with the exact cause being unidentified in the majority of cases. Researchers at the National Institute of Mental Health (NIMH) suggest the factors affecting mental illness include heredity, brain injuries, low birth weight, drugs use during pregnancy and exposure to environmental toxins such, as lead at young age. The currently available treatments, such as medication, counseling, lifestyle changes or a combination of these treatments helps in reducing symptoms with improved functioning of patient. Download PDF Brochure @ Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/830 https://www.coherentmarketinsights.com/insight/request-pdf/830 Rising number of drug-treated patients for ADHD therapy is expected to drive the attention deficit Rising number of drug-treated patients for ADHD therapy is expected to drive the attention deficit hyperactivity disorder (ADHD) treatment market hyperactivity disorder (ADHD) treatment market According to the National Institute of Health estimates in 2015, the prevalence of ADHD is higher by 30% in boys, with 5.1 million children being diagnosed with ADHD globally in 2013 and the number expected to rise to 18 million by 2020. Increasing awareness of ADHD symptoms among patients and physicians, opinion-based diagnosis owing to the absence of standard diagnostic tests is expected to boost the revenue growth of ADHD therapeutics market in the forecast period. Additionally, rise in the ADHD therapeutics market is driven by increasing use of additives and preservatives in diet, value systems impacting quality of births, and changing lifestyles. However, restricted availability of non-stimulants ADHD drugs and existence of multiple conditions like schizophrenia or depression in children leads to underdiagnoses of ADHD in various geographies including Middle East and Africa, thereby restraining the growth of the market over the forecast period. Since Adderall abuse has grown to epidemic levels, our research team has compiled an article about the best all-natural alternatives to Adderall.
Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Research Objective and Assumption • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market, By Regions • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Drug development and market consolidation strategies fuel the demand of some manufacturers Drug development and market consolidation strategies fuel the demand of some manufacturers Key players operating the attention deficit hyperactivity disorder (ADHD) treatment market include Eli Lilly, GlaxoSmithKline PLC, Pfizer Inc, Novartis AG and Shire PLC. The key strategies adopted by the manufacturers are developing cost-efficient drugs, which are safe for consumption and market consolidations. The other key vendors include Impax Laboratories, Hisamitsu Pharmaceutical Inc., Mallinckrodt Pharmaceuticals Inc., UCB S.A., Purdue Parma L.P and Johnson & Johnson.
The non-stimulants market segment accounts for highest revenue share owing to its efficient treatment The non-stimulants market segment accounts for highest revenue share owing to its efficient treatment improving focus and impulsivity improving focus and impulsivity The global attention deficit hyperactivity disorder (ADHD) treatment market is segmented on the basis of drug type, distribution channel and geography. On the basis of drug type, the global attention deficit hyperactivity disorder (ADHD) treatment market is On the basis of drug type, the global attention deficit hyperactivity disorder (ADHD) treatment market is segmented into: segmented into: • Stimulants Stimulants o Amphetamine o Methylphenidate o Dexmethylphenidate o Dextroamphetamine o Lisdexamfetamine Dimesylate • Non-stimulants • Non-stimulants o Atomoxetine o Clonidine o Guanfacine o Bupropion On the basis of therapy, the global attention deficit hyperactivity disorder (ADHD) treatment market is On the basis of therapy, the global attention deficit hyperactivity disorder (ADHD) treatment market is segmented into: segmented into: • Behavior Therapy • Cognitive Behavioral Therapy • Interpersonal Psychotherapy • Family Therapy Browse Full Exclusive Research Report at Browse Full Exclusive Research Report at https://www.coherentmarketinsights.com/ongoing- https://www.coherentmarketinsights.com/ongoing- insight/attention-deficit-hyperactivity-disorder-treatment-market-830 insight/attention-deficit-hyperactivity-disorder-treatment-market-830
About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com